Primary Endpoint Analysis from a Response Adaptive Phase II Clinical Trial of Carfilzomib, Lenalidomide, Dexamethasone Plus Daratumumab (KRd-Dara) in Patients with Newly Diagnosed... by Bhutani, Manisha, Robinson, Myra, Atrash, Shebli, Paul, Barry, Pineda-Roman, Mauricio, Foureau, David, Varga, Cindy, Friend, Reed, Begic, Xhevahire, Norek, Sarah, Drennan, Tiffany, Anderson, Michelle B, Symanowski, James, Voorhees, Peter M., Usmani, Saad Z

Get full text

MRD-driven phase 2 study of daratumumab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma by Bhutani, Manisha, Robinson, Myra, Foureau, David, Atrash, Shebli, Paul, Barry A, Guo, Fei, Grayson, Jason, Ivanina-Foureau, Anna, Pineda-Roman, Mauricio, Varga, Cindy, Friend, Reed, Ferreri, Christopher J, Begic, Xhevahire, Norek, Sarah, Drennan, Tiffany, Anderson, Michelle B, Symanowski, James T, Voorhees, Peter M, Usmani, Saad Z

Get full text

Factors associated with out-of-hospital cardiac arrest with pulseless electric activity: A population based study by Ko, Dennis T., MD, MSc, Qiu, Feng, MSc, Koh, Maria, MSc, Dorian, Paul, MD, Cheskes, Sheldon, MD, Austin, Peter C., PhD, Scales, Damon C., MD, Wijeysundera, Harindra C., MD, PhD, Verbeek, P. Richard, MD, Drennan, Ian, BSc, PCP, Ng, Tiffany, MBBS, MSc, Tu, Jack V., MD, PhD, Morrison, Laurie J., MD

Get full text